The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger...

Socially isolated older adults are at increased risk of developing diabetes and high blood sugar, according to a study being presented Sunday at ENDO...

Exposure to endocrine-disrupting chemicals in early life, including during gestation and infancy, results in a higher preference for sugary and fatty...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being...

Consuming certain sweeteners commonly found in foods and beverages may increase the risk of early puberty in children, particularly among those who...

Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people...

The age at which a woman has her first period can offer valuable clues about her long-term risk for conditions like obesity, diabetes, heart disease...

MONDAY, July 14, 2025 -- From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the...

A grandfather's exposure to endocrine-disrupting chemicals may impact the age when his granddaughter starts her first period, according to preliminary...